A Match Made in Oncology: Optimising Co-Development Partnerships for the Accelerated Approval of Precision Oncology Therapies
Time: 4:40 pm
day: Day 1 - Track B (2)
Details:
- How soon should biopharma and diagnostic providers initiate collaboration to optimise the development of companion diagnostics for precision oncology?
- How and when to initiate performance studies to collect and establish data for the CDx
- What are the key challenges in scaling up co-development partnerships for precision oncology therapies, and how can these challenges be mitigated?
- What is the impact and opportunity of dual-pharmaceutical alliances on the co-development of precision therapies?
